ChinaDaily Briefs

Daily Brief China: Tian Tu Capital, Beneunder, Innovent Biologics Inc, Lenovo and more

In today’s briefing:

  • Tian Tu Capital Pre-IPO Tearsheet
  • Beneunder Pre-IPO – The Positives – Basking in the Sun
  • Innovent Biologics Inc (1801.HK) – Innovent Is Not Optional but Necessary in Portfolio
  • Lenovo – Event Flash – Dual-Tranche Bond Offering And Tender Offer – Lucror Analytics
  • Beneunder Pre-IPO – The Negatives – Doubts Remain, Including Related Party Dealings
  • Morning Views Asia: China South City, Lenovo

Tian Tu Capital Pre-IPO Tearsheet

By Ethan Aw

  • Tian Tu Capital (1390587D CH) is looking to raise about US$500m in its upcoming Hong Kong IPO. The deal will be run by JP Morgan and Huatai International.
  • Tian Tu Capital is a private equity investor that invests in Chinese consumer brands/companies, managing capital for institutional investors and high-net worth individuals.  
  • Among the 205 portfolio companies it had invested in up to FY21 (Dec 31, 2021), 23 of them had reached a valuation of US$1bn at that date. 

Beneunder Pre-IPO – The Positives – Basking in the Sun

By Sumeet Singh

  • Beneunder Limited (BL) aims to raise around US$500m in its Hong Kong IPO.
  • According to CIC, it was the largest sunprotection apparel brand in China in terms of both total retail sales value and online retail sales value with 5.0% and 12.9% marketshare. 
  • In this note, we will talk about the positive aspects of the deal.

Innovent Biologics Inc (1801.HK) – Innovent Is Not Optional but Necessary in Portfolio

By Xinyao (Criss) Wang

  • Innovent is expected to transform from a biotech to a biopharma. From the present point of view, the Company is a better comprehensive choice of certainty, elasticity and safety.  
  • With high R&D efficiency, strong sales capability, top talent teams, and mindset keeping pace with the times, investors could consider to replace Hengrui with Innovent in the portfolio.  
  • Innovent’s valuation anchor is HK$40 billion, below which it’s undervalued. Its market value could reach about RMB80 billion to RMB120 billion, based on sales of RMB10 billion to RMB15 billion. 

Lenovo – Event Flash – Dual-Tranche Bond Offering And Tender Offer – Lucror Analytics

By Trung Nguyen

Lenovo has launched a roadshow to market dual-tranche 144A/RegS bond offerings of 5.5Y and 10Y. The 10Y notes will be the company’s first green bonds, while the 5.5Y bonds will be conventional notes. Proceeds from the green bonds will be used to finance or refinance eligible projects, including green buildings and renewable energy initiatives. 

Lenovo also launched a concurrent tender offer for the USD 4.75 23 notes, of which USD 687 mn is outstanding. The tender offer price is USD 1,005 per USD 1,000 principal. The consideration will include accrued interest. The tender cap will be determined and announced on or around July 22nd, after the company has priced the notes offerings.

Initial price guidance was announced earlier today, as follows: 5.5Y: CT5 + 290 bps, and 10Y: CT10 + 370 bps. We find this fair, in view of the existing LENOVO curve and taking into account global peers HPQ and DELL.


Beneunder Pre-IPO – The Negatives – Doubts Remain, Including Related Party Dealings

By Sumeet Singh

  • Beneunder Limited (BL) aims to raise around US$500m in its Hong Kong IPO.
  • According to CIC, it was the largest sunprotection apparel brand in China in terms of both total retail sales value and online retail sales value with 5.0% and 12.9% marketshare. 
  • In this note, we will talk about the not-so-positive aspects of the deal.

Morning Views Asia: China South City, Lenovo

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars